Giada Franco, Gulizia Michele, Francese Maura, Croci Francesco, Santangelo Lucio, Santomauro Maurizio, Occhetta Eraldo, Menozzi Carlo, Raviele Antonio
Cardiovascular Department, Ospedale Umberto I, Mestre-Venice, Venice, Italy.
J Am Coll Cardiol. 2007 May 15;49(19):1951-6. doi: 10.1016/j.jacc.2007.02.036. Epub 2007 Apr 30.
The aim of the study was to compare the diagnostic yield and the costs of implantable loop recorder (ILR) with those of the conventional strategy in patients with unexplained palpitations.
In patients with unexplained palpitations, especially in those with infrequent symptoms, the conventional strategy, including short-term ambulatory electrocardiogram (ECG) monitoring and electrophysiological study, sometimes fails to establish a diagnosis.
We studied 50 patients with infrequent (< or =1 episode/month), sustained (>1 min) palpitations. Before enrollment, patients had a negative initial evaluation, including history, physical examination, and ECG. Patients were randomized either to conventional strategy (24-h Holter recording, a 4-week period of ambulatory ECG monitoring with an external recorder, and electrophysiological study) (n = 24) or to ILR implantation with 1-year monitoring (n = 26). Hospital costs of the 2 strategies were calculated.
A diagnosis was obtained in 5 patients in the conventional strategy group, and in 19 subjects in the ILR group (21% vs. 73%, p < 0.001). Despite the higher initial cost, the cost per diagnosis in the ILR group was lower than in the conventional strategy group (euro 3,056 +/- euro 363 vs. euro 6,768 +/- euro 6,672, p = 0.012).
In subjects without severe heart disease and with infrequent palpitations, ILR is a safe and more cost-effective diagnostic approach than conventional strategy.
本研究旨在比较植入式环路记录器(ILR)与传统策略对不明原因心悸患者的诊断率及成本。
对于不明原因心悸的患者,尤其是症状不频繁者,包括短期动态心电图(ECG)监测和电生理检查在内的传统策略有时无法确诊。
我们研究了50例心悸发作不频繁(≤1次/月)且持续时间较长(>1分钟)的患者。入选前,患者的初始评估(包括病史、体格检查和心电图)均为阴性。患者被随机分为传统策略组(24小时动态心电图记录、使用外部记录器进行为期4周的动态心电图监测以及电生理检查)(n = 24)或ILR植入并进行1年监测组(n = 26)。计算两种策略的住院费用。
传统策略组有5例患者确诊,ILR组有19例患者确诊(21%对73%,p < 0.001)。尽管ILR组初始成本较高,但其每例诊断的成本低于传统策略组(3056欧元±363欧元对6768欧元±6672欧元,p = 0.012)。
对于无严重心脏病且心悸发作不频繁的患者,ILR是一种比传统策略更安全且更具成本效益的诊断方法。